Seroatlas · Human Serome Atlas

COX6A1

Cytochrome c oxidase subunit 6A1, mitochondrial

Also known as: COX6A, COX6AL, CX6A1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P12074
Gene
COX6A1
Ensembl
ENSG00000111775
Chromosome
12
Canonical length
109 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
Subcellular location
Mitochondria,Principal piece

OverviewNCBI Gene

Cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. It is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in the electron transfer and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes polypeptide 1 (liver isoform) of subunit VIa, and polypeptide 1 is found in all non-muscle tissues. Polypeptide 2 (heart/muscle isoform) of subunit VIa is encoded by a different gene, and is present only in striated muscles. These two polypeptides share 66% amino acid sequence identity. It has been reported that there may be several pseudogenes on chromosomes 1, 6, 7q21, 7q31-32 and 12. However, only one pseudogene (COX6A1P) on chromosome 1p31.1 has been documented. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

109 residues, UniProt reviewed canonical sequence.

>P12074|COX6A1
     1  MAVVGVSSVS RLLGRSRPQL GRPMSSGAHG EEGSARMWKT LTFFVALPGV AVSMLNVYLK
    61  SHHGEHERPE FIAYPHLRIR TKPFPWGDGN HTLFHNPHVN PLPTGYEDE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against COX6A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
1,832 nTPM

Expression across tissuesHPA

Tissue

  • amygdala: 1,832 nTPM
  • midbrain: 1,427 nTPM
  • cerebral cortex: 1,404 nTPM
  • hippocampal formation: 1,237 nTPM
  • basal ganglia: 988 nTPM
  • hypothalamus: 930 nTPM

Single-cell type

  • parietal cells: 911 nCPM
  • enterocytes: 444 nCPM
  • colonocytes: 296 nCPM
  • enteric transient amplifying cells: 240 nCPM
  • gastric chief cells: 170 nCPM
  • enteric stem cells: 170 nCPM

Immune cell

  • total PBMC: 535 nTPM
  • plasmacytoid DC: 518 nTPM
  • myeloid DC: 489 nTPM
  • T-reg: 462 nTPM
  • memory B-cell: 379 nTPM
  • non-classical monocyte: 376 nTPM

Brain region

  • thalamus: 700 nTPM
  • hypothalamus: 683 nTPM
  • pons: 662 nTPM
  • medulla oblongata: 634 nTPM
  • cerebellum: 610 nTPM
  • cerebral cortex: 602 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about COX6A1.

Disease | AllUniProt

Conditions COX6A1 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 118 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.76
gnomAD pLI
0
gnomAD missense Z
-1.42
DepMap mean gene effect
-0.56
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads COX6A1 as an antibody target. Whether an autoantibody or antibody against COX6A1 could matter depends on whether native COX6A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

COX6A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label COX6A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/COX6A1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...